Drug Patents owned by Ge Healthcare
1. Drug name - MYOVIEW
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9549999 | GE HEALTHCARE | Radiopharmaceutical composition |
Mar, 2030
(7 years from now) | |
Drugs and Companies using TECHNETIUM TC-99M TETROFOSMIN KIT ingredient
Treatment: NA
Dosage: INJECTABLE;INJECTION
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| N/A | INJECTABLE;INJECTION | Prescription |
2. Drug name - VIZAMYL
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7351401 | GE HEALTHCARE | Thioflavin derivatives for use in the antemortem diagnosis of Alzheimers disease and in vivo imaging and prevention of amyloid deposition |
Jan, 2023
(3 months from now) | |
| US8236282 | GE HEALTHCARE | Benzothiazole derivative compounds, compositions and uses |
May, 2024
(1 year, 7 months from now) | |
| US7270800 | GE HEALTHCARE | Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
Sep, 2025
(2 years from now) | |
| CN1784392A | GE HEALTHCARE | Benzothiazole Derivative Compounds, Compositions And Use |
Aug, 2012
(10 years ago) | |
| CN1285582C | GE HEALTHCARE | For Diagnosis Of Presenile Dementia And Amyloid Deposition In Vivo Imaging And Prevention Of Sulfur Flavin Derivatives |
Aug, 2021
(1 year, 1 month ago) | |
| CN1535268A | GE HEALTHCARE | For Diagnosis Of Presenile Dementia And Amyloid Deposition In Vivo Imaging And Prevention Of Sulfur Flavin Derivatives |
Aug, 2021
(1 year, 1 month ago) | |
| CN102532055A | GE HEALTHCARE | Benzothiazole Derivative Compounds, Compositions And Uses Thereof |
Mar, 2024
(1 year, 5 months from now) | |
| CN102532055B | GE HEALTHCARE | Benzothiazole Derivative Compounds, Compositions And Use |
Mar, 2024
(1 year, 5 months from now) | |
| EP2264018A3 | GE HEALTHCARE | Thioflavin Derivatives For Use In The Diagnosis Of Alzheimer'S Disease |
Aug, 2021
(1 year, 1 month ago) | |
| EP1334091B1 | GE HEALTHCARE | Thioflavin Derivatives And Their Use In Diagnosis And Therapy Of Alzheimer'S Disease |
Aug, 2021
(1 year, 1 month ago) | |
| EP2264018B1 | GE HEALTHCARE | Thioflavin Derivatives For Use In The Diagnosis Of Alzheimer'S Disease |
Aug, 2021
(1 year, 1 month ago) | |
| EP1334091A2 | GE HEALTHCARE | Thioflavin Derivatives And Their Use In Diagnosis And Therapy Of Alzheimer'S Disease |
Aug, 2021
(1 year, 1 month ago) | |
| EP2264018A2 | GE HEALTHCARE | Thioflavin Derivatives For Use In The Diagnosis Of Alzheimer'S Disease |
Aug, 2021
(1 year, 1 month ago) | |
| EP1611115A1 | GE HEALTHCARE | Benzothiazole Derivative Compounds, Compositions And Uses |
Mar, 2029
(6 years from now) | |
| EP1611115B1 | GE HEALTHCARE | Benzothiazole Derivative Compounds, Compositions And Uses |
Mar, 2029
(6 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8691185 | GE HEALTHCARE | Benzothiazole derivative compounds, compositions and uses |
Jan, 2023
(3 months from now) | |
| US8916131 | GE HEALTHCARE | Radiopharmaceutical composition |
Sep, 2028
(5 years from now) | |
Drugs and Companies using FLUTEMETAMOL F-18 ingredient
Treatment: Diagnostic radioimaging
Dosage: INJECTABLE;INTRAVENOUS
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 40.5mCi/10ML (4.05mCi/ML) | INJECTABLE;INTRAVENOUS | Discontinued |
| 121.5mCi/30ML (4.05mCi/ML) | INJECTABLE;INTRAVENOUS | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.